FMR CORP 13D and 13G filings for Longboard Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-07 09:26 am Sale |
2024-11-06 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
FMR CORP | 545,108 1.401% |
-3,804,991 (-87.47%) |
Filing |
| 2024-11-07 09:12 am Sale |
2024-11-06 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
FMR CORP | 4,350,099 11.182% |
-156,368 (-3.47%) |
Filing |
| 2024-03-11 08:19 am Purchase |
2024-03-08 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
FMR CORP | 4,506,467 12.749% |
2,856,964 (+173.20%) |
Filing |
| 2024-02-09 09:16 am Sale |
2024-02-08 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
FMR CORP | 1,649,503 7.694% |
-297,813 (-15.29%) |
Filing |
| 2023-11-13 09:02 am Sale |
2023-11-10 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
FMR CORP | 1,947,316 9.472% |
-953,076 (-32.86%) |
Filing |
| 2023-03-10 09:30 am Purchase |
2023-03-09 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
FMR CORP | 2,900,392 14.999% |
1,795,488 (+162.50%) |
Filing |
| 2023-02-09 12:48 pm Sale |
2023-02-09 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
FMR CORP | 1,104,904 8.132% |
-410,678 (-27.10%) |
Filing |
| 2022-02-09 09:22 am Sale |
2022-02-08 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
FMR CORP | 1,515,582 11.155% |
-477,554 (-23.96%) |
Filing |
| 2021-04-12 1:05 pm Purchase |
2021-04-09 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
FMR CORP | 1,993,136 14.999% |
1,993,136 (New Position) |
Filing |